Exact Mass: 761.5958

Exact Mass Matches: 761.5958

Found 201 metabolites which its exact mass value is equals to given mass value 761.5958, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

PC(18:0/16:0)

(2-{[(2R)-2-(hexadecanoyloxy)-3-(octadecanoyloxy)propyl phosphonato]oxy}ethyl)trimethylazanium

C42H84NO8P (761.5934)


PC(18:0/16:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:0/16:0), in particular, consists of one chain of stearic acid at the C-1 position and one chain of palmitic acid at the C-2 position. The stearic acid moiety is derived from animal fats, coco butter and sesame oil, while the palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. PC(18:0/16:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(18:0/16:0), in particular, consists of one chain of stearic acid at the C-1 position and one chain of palmitic acid at the C-2 position. The stearic acid moiety is derived from animal fats, coco butter and sesame oil, while the palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PC(16:0/18:0)

(2-{[(2R)-3-(hexadecanoyloxy)-2-(octadecanoyloxy)propyl phosphono]oxy}ethyl)trimethylazanium

C42H84NO8P (761.5934)


PC(16:0/18:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(16:0/18:0), in particular, consists of one chain of palmitic acid at the C-1 position and one chain of stearic acid at the C-2 position. The palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats, while the stearic acid moiety is derived from animal fats, coco butter and sesame oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. PC(16:0/18:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(16:0/18:0), in particular, consists of one chain of palmitic acid at the C-1 position and one chain of stearic acid at the C-2 position. The palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats, while the stearic acid moiety is derived from animal fats, coco butter and sesame oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PC(14:0/20:0)

(2-{[(2R)-2-(icosanoyloxy)-3-(tetradecanoyloxy)propyl phosphonato]oxy}ethyl)trimethylazanium

C42H84NO8P (761.5934)


PC(14:0/20:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(14:0/20:0), in particular, consists of one chain of myristic acid at the C-1 position and one chain of arachidic acid at the C-2 position. The myristic acid moiety is derived from nutmeg and butter, while the arachidic acid moiety is derived from peanut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. PC(14:0/20:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(14:0/20:0), in particular, consists of one chain of myristic acid at the C-1 position and one chain of arachidic acid at the C-2 position. The myristic acid moiety is derived from nutmeg and butter, while the arachidic acid moiety is derived from peanut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PC(20:0/14:0)

(2-{[(2R)-3-(icosanoyloxy)-2-(tetradecanoyloxy)propyl phosphonato]oxy}ethyl)trimethylazanium

C42H84NO8P (761.5934)


PC(20:0/14:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(20:0/14:0), in particular, consists of one chain of arachidic acid at the C-1 position and one chain of myristic acid at the C-2 position. The arachidic acid moiety is derived from peanut oil, while the myristic acid moiety is derived from nutmeg and butter. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. PC(20:0/14:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(20:0/14:0), in particular, consists of one chain of arachidic acid at the C-1 position and one chain of myristic acid at the C-2 position. The arachidic acid moiety is derived from peanut oil, while the myristic acid moiety is derived from nutmeg and butter. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PE(15:0/22:0)

(2-aminoethoxy)[(2R)-2-(docosanoyloxy)-3-(pentadecanoyloxy)propoxy]phosphinic acid

C42H84NO8P (761.5934)


PE(15:0/22:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(15:0/22:0), in particular, consists of one chain of pentadecanoic acid at the C-1 position and one chain of behenic acid at the C-2 position. The pentadecanoic acid moiety is derived from dairy products and milk fat, while the behenic acid moiety is derived from groundnut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. PE(15:0/22:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(15:0/22:0), in particular, consists of one chain of pentadecanoic acid at the C-1 position and one chain of behenic acid at the C-2 position. The pentadecanoic acid moiety is derived from dairy products and milk fat, while the behenic acid moiety is derived from groundnut oil. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PE(22:0/15:0)

(2-aminoethoxy)[(2R)-3-(docosanoyloxy)-2-(pentadecanoyloxy)propoxy]phosphinic acid

C42H84NO8P (761.5934)


PE(22:0/15:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(22:0/15:0), in particular, consists of one chain of behenic acid at the C-1 position and one chain of pentadecanoic acid at the C-2 position. The behenic acid moiety is derived from groundnut oil, while the pentadecanoic acid moiety is derived from dairy products and milk fat. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. PE(22:0/15:0) is a phosphatidylethanolamine (PE or GPEtn). It is a glycerophospholipid in which a phosphorylethanolamine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphoethanolamines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PE(22:0/15:0), in particular, consists of one chain of behenic acid at the C-1 position and one chain of pentadecanoic acid at the C-2 position. The behenic acid moiety is derived from groundnut oil, while the pentadecanoic acid moiety is derived from dairy products and milk fat. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PE-NMe(18:0/18:0)

[3-[Hydroxy-[2-(methylamino)ethoxy]phosphoryl]oxy-2-octadecanoyloxypropyl] octadecanoate

C42H84NO8P (761.5934)


PE-NMe(18:0/18:0) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(18:0/18:0), in particular, consists of two octadecanoyl chain at positions C-1 and C2. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.

   

PE-NMe(14:0/22:0)

[2-(docosanoyloxy)-3-(tetradecanoyloxy)propoxy][2-(methylamino)ethoxy]phosphinic acid

C42H84NO8P (761.5934)


PE-NMe(14:0/22:0) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(14:0/22:0), in particular, consists of one chain of myristic acid at the C-1 position and one chain of behenic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

   

PE-NMe(16:0/20:0)

[3-(hexadecanoyloxy)-2-(icosanoyloxy)propoxy][2-(methylamino)ethoxy]phosphinic acid

C42H84NO8P (761.5934)


PE-NMe(16:0/20:0) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(16:0/20:0), in particular, consists of one chain of palmitic acid at the C-1 position and one chain of arachidic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

   

PE-NMe(20:0/16:0)

[2-(hexadecanoyloxy)-3-(icosanoyloxy)propoxy][2-(methylamino)ethoxy]phosphinic acid

C42H84NO8P (761.5934)


PE-NMe(20:0/16:0) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(20:0/16:0), in particular, consists of one chain of arachidic acid at the C-1 position and one chain of palmitic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

   

PE-NMe(22:0/14:0)

[3-(docosanoyloxy)-2-(tetradecanoyloxy)propoxy][2-(methylamino)ethoxy]phosphinic acid

C42H84NO8P (761.5934)


PE-NMe(22:0/14:0) is a monomethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Monomethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe(22:0/14:0), in particular, consists of one chain of behenic acid at the C-1 position and one chain of myristic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

   

PE-NMe2(15:0/20:0)

[2-(dimethylamino)ethoxy][2-(icosanoyloxy)-3-(pentadecanoyloxy)propoxy]phosphinic acid

C42H84NO8P (761.5934)


PE-NMe2(15:0/20:0) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(15:0/20:0), in particular, consists of one chain of pentadecanoic acid at the C-1 position and one chain of arachidic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

   

PE-NMe2(20:0/15:0)

[2-(dimethylamino)ethoxy][3-(icosanoyloxy)-2-(pentadecanoyloxy)propoxy]phosphinic acid

C42H84NO8P (761.5934)


PE-NMe2(20:0/15:0) is a dimethylphosphatidylethanolamine. It is a glycerophospholipid, and it is formed by sequential methylation of phosphatidylethanolamine as part of a mechanism for biosynthesis of phosphatidylcholine. Dimethylphosphatidylethanolamines are usually found at trace levels in animal or plant tissues. They can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PE-NMe2(20:0/15:0), in particular, consists of one chain of arachidic acid at the C-1 position and one chain of pentadecanoic acid at the C-2 position. Fatty acids containing 16, 18 and 20 carbons are the most common. Phospholipids are ubiquitous in nature. They are key components of the cell lipid bilayer and are involved in metabolism and signaling.

   

Asteriacerebroside E

Asteriacerebroside E

C42H83NO10 (761.6017)


   

3,4-dihydroxy-2-(2-hydroxyeicosanoylamino)hexadecyl-beta-D-glucopyranoside

3,4-dihydroxy-2-(2-hydroxyeicosanoylamino)hexadecyl-beta-D-glucopyranoside

C42H83NO10 (761.6017)


   

1-O-beta-D-glucopyranosyl-(2S,3S,4R)-2-[(2R)-2-hydroxyoctadecanoylamino]-16-methyl-heptadeca-1,3,4-triol|renieroside C8

1-O-beta-D-glucopyranosyl-(2S,3S,4R)-2-[(2R)-2-hydroxyoctadecanoylamino]-16-methyl-heptadeca-1,3,4-triol|renieroside C8

C42H83NO10 (761.6017)


   

Phosphatidylcholine 18:0-16:0

Phosphatidylcholine 18:0-16:0

C42H84NO8P (761.5934)


   

Phosphatidylcholine 16:0-18:0

Phosphatidylcholine 16:0-18:0

C42H84NO8P (761.5934)


   

PC 34:0

1-nonadecanoyl-2-pentadecanoyl-sn-glycero-3-phosphocholine

C42H84NO8P (761.5934)


Found in mouse brain; TwoDicalId=92; MgfFile=160720_brain_EPA_06_Neg; MgfId=1365

   

[2,3-di(heptadecanoyloxy)propyl] 2-(trimethylazaniumyl)ethyl phosphate

[2,3-di(heptadecanoyloxy)propyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H84NO8P (761.5934)


   

PC(13:0/21:0)

3,5,8-Trioxa-4-phosphanonacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-9-oxo-7-[[(1-oxotridecyl)oxy]methyl]-, inner salt, 4-oxide, (R)-

C42H84NO8P (761.5934)


   

PC(15:0/19:0)

3,5,8-Trioxa-4-phosphaheptacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-9-oxo-7-[[(1-oxopentadecyl)oxy]methyl]-, inner salt, 4-oxide, (R)-

C42H84NO8P (761.5934)


   

PC(16:0/18:0)[U]

3,5,8-Trioxa-4-phosphahexacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-9-oxo-7-[[(1-oxohexadecyl)oxy]methyl]-, inner salt, 4-oxide

C42H84NO8P (761.5934)


   

PC(17:0/17:0)

1,2-diheptadecanoyl-sn-glycero-3-phosphocholine

C42H84NO8P (761.5934)


   

PC(17:0/17:0)[U]

3,5,9-Trioxa-4-phosphahexacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxoheptadecyl)oxy]-, inner salt, 4-oxide

C42H84NO8P (761.5934)


   

PC(18:0/16:0)[U]

Stearin, 2-palmito-1-, dihydrogen phosphate, monoester with choline hydroxide, inner salt

C42H84NO8P (761.5934)


   

PC(19:0/15:0)

3,5,9-Trioxa-4-phosphaoctacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxopentadecyl)oxy]-, inner salt, 4-oxide, (R)-

C42H84NO8P (761.5934)


   

PC(21:0/13:0)

3,5,9-Trioxa-4-phosphatriacontan-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxotridecyl)oxy]-, inner salt, 4-oxide, (R)-

C42H84NO8P (761.5934)


   

PC(22:0/12:0)

3,5,9-Trioxa-4-phosphahentriacontan-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxododecyl)oxy]-, inner salt, 4-oxide, (R)-

C42H84NO8P (761.5934)


   

PC(22:0/12:0)[U]

3,5,9-Trioxa-4-phosphahentriacontan-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxododecyl)oxy]-, inner salt, 4-oxide

C42H84NO8P (761.5934)


   

PC(23:0/11:0)[U]

3,5,9-Trioxa-4-phosphadotriacontan-1-aminium, 4-hydroxy-N,N,N-trimethyl-10-oxo-7-[(1-oxoundecyl)oxy]-, inner salt, 4-oxide

C42H84NO8P (761.5934)


   

PC(14:0/20:0)[U]

3,5,8-Trioxa-4-phosphaoctacosan-1-aminium, 4-hydroxy-N,N,N-trimethyl-9-oxo-7-[[(1-oxotetradecyl)oxy]methyl]-, inner salt, 4-oxide

C42H84NO8P (761.5934)


   

PE(17:0/20:0)

Eicosanoic acid, 1-[[[(2-aminoethoxy)hydroxyphosphinyl]oxy]methyl]-2-[(1-oxoheptadecyl)oxy]ethyl ester, (R)-

C42H84NO8P (761.5934)


   

PE(18:0/19:0)[U]

Nonadecanoic acid, 1-[[[(2-aminoethoxy)hydroxyphosphinyl]oxy]methyl]-2-[(1-oxooctadecyl)oxy]ethyl ester

C42H84NO8P (761.5934)


   

PE(20:0/17:0)[U]

1-eicosanoyl-2-heptadecanoyl-sn-glycero-3-phosphoethanolamine

C42H84NO8P (761.5934)


   

PE(19:0/18:0)[U]

1-nonadecanoyl-2-octadecanoyl-sn-glycero-3-phosphoethanolamine

C42H84NO8P (761.5934)


   

PE(21:0/16:0)[U]

1-heneicosanoyl-2-hexadecanoyl-sn-glycero-3-phosphoethanolamine

C42H84NO8P (761.5934)


   

PE(16:0/21:0)[U]

1-hexadecanoyl-2-heneicosanoyl-sn-glycero-3-phosphoethanolamine

C42H84NO8P (761.5934)


   

PE(14:0/23:0)[U]

1-tetradecanoyl-2-tricosanoyl-sn-glycero-3-phosphoethanolamine

C42H84NO8P (761.5934)


   

GPEtnNMe(18:0/18:0)[U]

Octadecanoic acid, 1-(3-hydroxy-2,4-dioxa-6-aza-3-phosphaoct-1-yl)-1,2-ethanediyl ester, P-oxide

C42H84NO8P (761.5934)


   

PE-NMe(18:0/18:0)

Octadecanoic acid, 1-(3-hydroxy-2,4-dioxa-6-aza-3-phosphaoct-1-yl)-1,2-ethanediyl ester, P-oxide, (R)-

C42H84NO8P (761.5934)


   

Lecithin

1-Arachidonyl-2-myristoyl-sn-glycero-3-phosphocholine

C42H84NO8P (761.5934)


   

PE(37:0)

1-Behenoyl-2-pentadecanoyl-sn-glycero-3-phosphoethanolamine

C42H84NO8P (761.5934)


   

PE(16:0/21:0)

1-hexadecanoyl-2-heneicosanoyl-glycero-3-phosphoethanolamine

C42H84NO8P (761.5934)


   

PE(18:0/19:0)

1-octadecanoyl-2-nonadecanoyl-glycero-3-phosphoethanolamine

C42H84NO8P (761.5934)


   

PE(20:0/17:0)

1-eicosanoyl-2-heptadecanoyl-glycero-3-phosphoethanolamine

C42H84NO8P (761.5934)


   

PE(21:0/16:0)

1-heneicosanoyl-2-hexadecanoyl-glycero-3-phosphoethanolamine

C42H84NO8P (761.5934)


   

PE(19:0/18:0)

1-nonadecanoyl-2-octadecanoyl-glycero-3-phosphoethanolamine

C42H84NO8P (761.5934)


   

PE 37:0

Eicosanoic acid, 1-[[[(2-aminoethoxy)hydroxyphosphinyl]oxy]methyl]-2-[(1-oxoheptadecyl)oxy]ethyl ester, (R)-

C42H84NO8P (761.5934)


   

PE-NMe 36:0

Octadecanoic acid, 1-(3-hydroxy-2,4-dioxa-6-aza-3-phosphaoct-1-yl)-1,2-ethanediyl ester, P-oxide, (R)-

C42H84NO8P (761.5934)


   

Lecithin Hydrogenated

(3-Hexadecanoyloxy-2-octadecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C42H84NO8P (761.5934)


   

1,2-Heptadecanoylphosphatidylcholine

1,2-Heptadecanoylphosphatidylcholine

C42H84NO8P (761.5934)


   

HexCer 16:0;3O/20:0;(2OH)

HexCer 16:0;3O/20:0;(2OH)

C42H83NO10 (761.6017)


   

N-(2-hydroxynonadecanoyl)-1-O-beta-D-glucosyl-4-hydroxy-15-methylhexadecasphinganine

N-(2-hydroxynonadecanoyl)-1-O-beta-D-glucosyl-4-hydroxy-15-methylhexadecasphinganine

C42H83NO10 (761.6017)


   

NAGly 26:6/21:2

NAGly 26:6/21:2

C49H79NO5 (761.5958)


   

NAGly 26:7/21:1

NAGly 26:7/21:1

C49H79NO5 (761.5958)


   

Lnape 15:0/N-22:0

Lnape 15:0/N-22:0

C42H84NO8P (761.5934)


   

Lnape 17:0/N-20:0

Lnape 17:0/N-20:0

C42H84NO8P (761.5934)


   

Lnape 24:0/N-13:0

Lnape 24:0/N-13:0

C42H84NO8P (761.5934)


   

Lnape 18:0/N-19:0

Lnape 18:0/N-19:0

C42H84NO8P (761.5934)


   

Lnape 16:0/N-21:0

Lnape 16:0/N-21:0

C42H84NO8P (761.5934)


   

Lnape 26:0/N-11:0

Lnape 26:0/N-11:0

C42H84NO8P (761.5934)


   

Lnape 21:0/N-16:0

Lnape 21:0/N-16:0

C42H84NO8P (761.5934)


   

Lnape 14:0/N-23:0

Lnape 14:0/N-23:0

C42H84NO8P (761.5934)


   

Lnape 19:0/N-18:0

Lnape 19:0/N-18:0

C42H84NO8P (761.5934)


   

Lnape 10:0/N-27:0

Lnape 10:0/N-27:0

C42H84NO8P (761.5934)


   

Lnape 11:0/N-26:0

Lnape 11:0/N-26:0

C42H84NO8P (761.5934)


   

Lnape 13:0/N-24:0

Lnape 13:0/N-24:0

C42H84NO8P (761.5934)


   

Lnape 22:0/N-15:0

Lnape 22:0/N-15:0

C42H84NO8P (761.5934)


   

Lnape 25:0/N-12:0

Lnape 25:0/N-12:0

C42H84NO8P (761.5934)


   

Lnape 20:0/N-17:0

Lnape 20:0/N-17:0

C42H84NO8P (761.5934)


   

Lnape 27:0/N-10:0

Lnape 27:0/N-10:0

C42H84NO8P (761.5934)


   

Lnape 12:0/N-25:0

Lnape 12:0/N-25:0

C42H84NO8P (761.5934)


   

Lnape 23:0/N-14:0

Lnape 23:0/N-14:0

C42H84NO8P (761.5934)


   

HexCer 8:0;3O/28:0;(2OH)

HexCer 8:0;3O/28:0;(2OH)

C42H83NO10 (761.6017)


   

HexCer 9:0;3O/27:0;(2OH)

HexCer 9:0;3O/27:0;(2OH)

C42H83NO10 (761.6017)


   

HexCer 11:0;3O/25:0;(2OH)

HexCer 11:0;3O/25:0;(2OH)

C42H83NO10 (761.6017)


   

HexCer 12:0;3O/24:0;(2OH)

HexCer 12:0;3O/24:0;(2OH)

C42H83NO10 (761.6017)


   

HexCer 10:0;3O/26:0;(2OH)

HexCer 10:0;3O/26:0;(2OH)

C42H83NO10 (761.6017)


   

HexCer 13:0;3O/23:0;(2OH)

HexCer 13:0;3O/23:0;(2OH)

C42H83NO10 (761.6017)


   

2-[[(11Z,14Z,17Z,20Z,23Z)-hexacosa-11,14,17,20,23-pentaenoyl]amino]-3-hydroxyicosane-1-sulfonic acid

2-[[(11Z,14Z,17Z,20Z,23Z)-hexacosa-11,14,17,20,23-pentaenoyl]amino]-3-hydroxyicosane-1-sulfonic acid

C46H83NO5S (761.5992)


   

(4E,8E,12E)-3-hydroxy-2-[[(11Z,14Z)-icosa-11,14-dienoyl]amino]hexacosa-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-3-hydroxy-2-[[(11Z,14Z)-icosa-11,14-dienoyl]amino]hexacosa-4,8,12-triene-1-sulfonic acid

C46H83NO5S (761.5992)


   

(4E,8E,12E)-2-[[(15Z,18Z)-hexacosa-15,18-dienoyl]amino]-3-hydroxyicosa-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-2-[[(15Z,18Z)-hexacosa-15,18-dienoyl]amino]-3-hydroxyicosa-4,8,12-triene-1-sulfonic acid

C46H83NO5S (761.5992)


   

(4E,8E,12E)-3-hydroxy-2-[[(13Z,16Z)-tetracosa-13,16-dienoyl]amino]docosa-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-3-hydroxy-2-[[(13Z,16Z)-tetracosa-13,16-dienoyl]amino]docosa-4,8,12-triene-1-sulfonic acid

C46H83NO5S (761.5992)


   

(4E,8E)-3-hydroxy-2-[[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]amino]hexacosa-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-[[(11Z,14Z,17Z)-icosa-11,14,17-trienoyl]amino]hexacosa-4,8-diene-1-sulfonic acid

C46H83NO5S (761.5992)


   

(4E,8E)-2-[[(10Z,13Z,16Z)-docosa-10,13,16-trienoyl]amino]-3-hydroxytetracosa-4,8-diene-1-sulfonic acid

(4E,8E)-2-[[(10Z,13Z,16Z)-docosa-10,13,16-trienoyl]amino]-3-hydroxytetracosa-4,8-diene-1-sulfonic acid

C46H83NO5S (761.5992)


   

2-[[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]amino]-3-hydroxytetracosane-1-sulfonic acid

2-[[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]amino]-3-hydroxytetracosane-1-sulfonic acid

C46H83NO5S (761.5992)


   

(E)-2-[[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoyl]amino]-3-hydroxytetracos-4-ene-1-sulfonic acid

(E)-2-[[(10Z,13Z,16Z,19Z)-docosa-10,13,16,19-tetraenoyl]amino]-3-hydroxytetracos-4-ene-1-sulfonic acid

C46H83NO5S (761.5992)


   

(E)-3-hydroxy-2-[[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]amino]hexacos-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-[[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]amino]hexacos-4-ene-1-sulfonic acid

C46H83NO5S (761.5992)


   

3-hydroxy-2-[[(9Z,12Z,15Z,18Z,21Z)-tetracosa-9,12,15,18,21-pentaenoyl]amino]docosane-1-sulfonic acid

3-hydroxy-2-[[(9Z,12Z,15Z,18Z,21Z)-tetracosa-9,12,15,18,21-pentaenoyl]amino]docosane-1-sulfonic acid

C46H83NO5S (761.5992)


   

(4E,8E)-3-hydroxy-2-[[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoyl]amino]docosa-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-[[(10Z,13Z,16Z)-tetracosa-10,13,16-trienoyl]amino]docosa-4,8-diene-1-sulfonic acid

C46H83NO5S (761.5992)


   

(4E,8E,12E)-2-[[(13Z,16Z)-docosa-13,16-dienoyl]amino]-3-hydroxytetracosa-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-2-[[(13Z,16Z)-docosa-13,16-dienoyl]amino]-3-hydroxytetracosa-4,8,12-triene-1-sulfonic acid

C46H83NO5S (761.5992)


   

3-hydroxy-2-[[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]amino]hexacosane-1-sulfonic acid

3-hydroxy-2-[[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]amino]hexacosane-1-sulfonic acid

C46H83NO5S (761.5992)


   

(E)-3-hydroxy-2-[[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoyl]amino]docos-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-[[(12Z,15Z,18Z,21Z)-tetracosa-12,15,18,21-tetraenoyl]amino]docos-4-ene-1-sulfonic acid

C46H83NO5S (761.5992)


   

(4E,8E,12E)-2-[[(11Z,14Z)-henicosa-11,14-dienoyl]amino]-3-hydroxypentacosa-4,8,12-triene-1-sulfonic acid

(4E,8E,12E)-2-[[(11Z,14Z)-henicosa-11,14-dienoyl]amino]-3-hydroxypentacosa-4,8,12-triene-1-sulfonic acid

C46H83NO5S (761.5992)


   

(E)-2-[[(14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoyl]amino]-3-hydroxyicos-4-ene-1-sulfonic acid

(E)-2-[[(14Z,17Z,20Z,23Z)-hexacosa-14,17,20,23-tetraenoyl]amino]-3-hydroxyicos-4-ene-1-sulfonic acid

C46H83NO5S (761.5992)


   

(4E,8E)-2-[[(12Z,15Z,18Z)-hexacosa-12,15,18-trienoyl]amino]-3-hydroxyicosa-4,8-diene-1-sulfonic acid

(4E,8E)-2-[[(12Z,15Z,18Z)-hexacosa-12,15,18-trienoyl]amino]-3-hydroxyicosa-4,8-diene-1-sulfonic acid

C46H83NO5S (761.5992)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-nonanoyloxypropan-2-yl] octacosanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-nonanoyloxypropan-2-yl] octacosanoate

C42H84NO8P (761.5934)


   

Cer 15:0;2O/18:5;(3OH)(FA 16:4)

Cer 15:0;2O/18:5;(3OH)(FA 16:4)

C49H79NO5 (761.5958)


   

Cer 17:0;2O/16:5;(3OH)(FA 16:4)

Cer 17:0;2O/16:5;(3OH)(FA 16:4)

C49H79NO5 (761.5958)


   

Cer 14:0;2O/16:4;(3OH)(FA 19:5)

Cer 14:0;2O/16:4;(3OH)(FA 19:5)

C49H79NO5 (761.5958)


   

Cer 14:0;2O/16:5;(3OH)(FA 19:4)

Cer 14:0;2O/16:5;(3OH)(FA 19:4)

C49H79NO5 (761.5958)


   

Cer 17:0;2O/16:4;(3OH)(FA 16:5)

Cer 17:0;2O/16:4;(3OH)(FA 16:5)

C49H79NO5 (761.5958)


   

Cer 15:0;2O/16:4;(3OH)(FA 18:5)

Cer 15:0;2O/16:4;(3OH)(FA 18:5)

C49H79NO5 (761.5958)


   

Cer 15:0;2O/18:4;(3OH)(FA 16:5)

Cer 15:0;2O/18:4;(3OH)(FA 16:5)

C49H79NO5 (761.5958)


   

Cer 15:0;2O/16:5;(3OH)(FA 18:4)

Cer 15:0;2O/16:5;(3OH)(FA 18:4)

C49H79NO5 (761.5958)


   

Cer 14:0;2O/19:5;(3OH)(FA 16:4)

Cer 14:0;2O/19:5;(3OH)(FA 16:4)

C49H79NO5 (761.5958)


   

Cer 14:0;2O/19:4;(3OH)(FA 16:5)

Cer 14:0;2O/19:4;(3OH)(FA 16:5)

C49H79NO5 (761.5958)


   
   

OxPC 34:0e+1O(1Cyc)

OxPC 34:0e+1O(1Cyc)

C42H84NO8P (761.5934)


   

HexCer 23:0;3O/13:0;(2OH)

HexCer 23:0;3O/13:0;(2OH)

C42H83NO10 (761.6017)


   

HexCer 14:0;3O/22:0;(2OH)

HexCer 14:0;3O/22:0;(2OH)

C42H83NO10 (761.6017)


   

HexCer 20:0;3O/16:0;(2OH)

HexCer 20:0;3O/16:0;(2OH)

C42H83NO10 (761.6017)


   

HexCer 24:0;3O/12:0;(2OH)

HexCer 24:0;3O/12:0;(2OH)

C42H83NO10 (761.6017)


   

HexCer 15:0;3O/21:0;(2OH)

HexCer 15:0;3O/21:0;(2OH)

C42H83NO10 (761.6017)


   

HexCer 19:0;3O/17:0;(2OH)

HexCer 19:0;3O/17:0;(2OH)

C42H83NO10 (761.6017)


   

HexCer 18:0;3O/18:0;(2OH)

HexCer 18:0;3O/18:0;(2OH)

C42H83NO10 (761.6017)


   

HexCer 21:0;3O/15:0;(2OH)

HexCer 21:0;3O/15:0;(2OH)

C42H83NO10 (761.6017)


   

HexCer 22:0;3O/14:0;(2OH)

HexCer 22:0;3O/14:0;(2OH)

C42H83NO10 (761.6017)


   

HexCer 17:0;3O/19:0;(2OH)

HexCer 17:0;3O/19:0;(2OH)

C42H83NO10 (761.6017)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-octanoyloxypropan-2-yl] nonacosanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-octanoyloxypropan-2-yl] nonacosanoate

C42H84NO8P (761.5934)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-octadecanoyloxypropan-2-yl] nonadecanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-octadecanoyloxypropan-2-yl] nonadecanoate

C42H84NO8P (761.5934)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-hexadecanoyloxypropan-2-yl] henicosanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-hexadecanoyloxypropan-2-yl] henicosanoate

C42H84NO8P (761.5934)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-tetradecanoyloxypropan-2-yl] tricosanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-tetradecanoyloxypropan-2-yl] tricosanoate

C42H84NO8P (761.5934)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecanoyloxypropan-2-yl] docosanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecanoyloxypropan-2-yl] docosanoate

C42H84NO8P (761.5934)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecanoyloxypropan-2-yl] icosanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecanoyloxypropan-2-yl] icosanoate

C42H84NO8P (761.5934)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-undecanoyloxypropan-2-yl] hexacosanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-undecanoyloxypropan-2-yl] hexacosanoate

C42H84NO8P (761.5934)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-dodecanoyloxypropan-2-yl] pentacosanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-dodecanoyloxypropan-2-yl] pentacosanoate

C42H84NO8P (761.5934)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-tridecanoyloxypropan-2-yl] tetracosanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-tridecanoyloxypropan-2-yl] tetracosanoate

C42H84NO8P (761.5934)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-decanoyloxypropan-2-yl] heptacosanoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-decanoyloxypropan-2-yl] heptacosanoate

C42H84NO8P (761.5934)


   

(2-Icosanoyloxy-3-tetradecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(2-Icosanoyloxy-3-tetradecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C42H84NO8P (761.5934)


   

(2-Tricosanoyloxy-3-undecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(2-Tricosanoyloxy-3-undecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C42H84NO8P (761.5934)


   

(3-Decanoyloxy-2-tetracosanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(3-Decanoyloxy-2-tetracosanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C42H84NO8P (761.5934)


   

(2-Heptacosanoyloxy-3-heptanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(2-Heptacosanoyloxy-3-heptanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C42H84NO8P (761.5934)


   

(2-Hexacosanoyloxy-3-octanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(2-Hexacosanoyloxy-3-octanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C42H84NO8P (761.5934)


   

(3-Nonanoyloxy-2-pentacosanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(3-Nonanoyloxy-2-pentacosanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C42H84NO8P (761.5934)


   

(2-Docosanoyloxy-3-dodecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(2-Docosanoyloxy-3-dodecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C42H84NO8P (761.5934)


   

(2-Henicosanoyloxy-3-tridecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(2-Henicosanoyloxy-3-tridecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C42H84NO8P (761.5934)


   

(2-Nonadecanoyloxy-3-pentadecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

(2-Nonadecanoyloxy-3-pentadecanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate

C42H84NO8P (761.5934)


   

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-dodecanoyloxypropyl] pentacosanoate

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-dodecanoyloxypropyl] pentacosanoate

C42H84NO8P (761.5934)


   

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-tridecanoyloxypropyl] tetracosanoate

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-tridecanoyloxypropyl] tetracosanoate

C42H84NO8P (761.5934)


   

[(2S)-3-icosanoyloxy-2-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2S)-3-icosanoyloxy-2-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H84NO8P (761.5934)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-dodecanoyloxypropan-2-yl] pentacosanoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-dodecanoyloxypropan-2-yl] pentacosanoate

C42H84NO8P (761.5934)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-undecanoyloxypropan-2-yl] hexacosanoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-undecanoyloxypropan-2-yl] hexacosanoate

C42H84NO8P (761.5934)


   

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hexadecanoyloxypropyl] henicosanoate

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hexadecanoyloxypropyl] henicosanoate

C42H84NO8P (761.5934)


   

[(2S)-3-henicosanoyloxy-2-tridecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2S)-3-henicosanoyloxy-2-tridecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H84NO8P (761.5934)


   

[(2S)-3-docosanoyloxy-2-dodecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2S)-3-docosanoyloxy-2-dodecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H84NO8P (761.5934)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tetradecanoyloxypropan-2-yl] tricosanoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tetradecanoyloxypropan-2-yl] tricosanoate

C42H84NO8P (761.5934)


   

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-pentadecanoyloxypropyl] docosanoate

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-pentadecanoyloxypropyl] docosanoate

C42H84NO8P (761.5934)


   

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-undecanoyloxypropyl] hexacosanoate

[(2S)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-undecanoyloxypropyl] hexacosanoate

C42H84NO8P (761.5934)


   

[(2S)-2-decanoyloxy-3-tetracosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2S)-2-decanoyloxy-3-tetracosanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H84NO8P (761.5934)


   

[(2R)-3-tricosanoyloxy-2-undecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[(2R)-3-tricosanoyloxy-2-undecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C42H84NO8P (761.5934)


   

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-tetradecanoyloxypropyl] tricosanoate

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-tetradecanoyloxypropyl] tricosanoate

C42H84NO8P (761.5934)


   

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tridecanoyloxypropan-2-yl] tetracosanoate

[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tridecanoyloxypropan-2-yl] tetracosanoate

C42H84NO8P (761.5934)


   

1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phosphocholine

1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phosphocholine

C42H84NO8P (761.5934)


A phosphatidylcholine 34:0 in which the 1- and 2-acyl groups are specified as hexadecanoyl (palmitoyl) and octadecanoyl (stearoyl) respectively.

   

1-stearoyl-2-palmitoyl-sn-glycero-3-phosphocholine

1-stearoyl-2-palmitoyl-sn-glycero-3-phosphocholine

C42H84NO8P (761.5934)


A phosphatidylcholine 34:0 in which the two acyl substituents at positions 1 and 2 are specified as stearoyl and palmitoyl respectively.

   

1-eicosanoyl-2-tetradecanoyl-sn-glycero-3-phosphocholine

1-eicosanoyl-2-tetradecanoyl-sn-glycero-3-phosphocholine

C42H84NO8P (761.5934)


   

1-Pentadecanoyl-2-docosanoyl-sn-glycero-3-phosphoethanolamine

1-Pentadecanoyl-2-docosanoyl-sn-glycero-3-phosphoethanolamine

C42H84NO8P (761.5934)


A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the 1- and 2-acyl groups are specified as pentadecanoyl and docosanoyl respectively.

   

1-Docosanoyl-2-pentadecanoyl-sn-glycero-3-phosphoethanolamine

1-Docosanoyl-2-pentadecanoyl-sn-glycero-3-phosphoethanolamine

C42H84NO8P (761.5934)


A 1,2-diacyl-sn-glycero-3-phosphoethanolamine in which the 1- and 2-acyl groups are specified as docosanoyl and pentadecanoyl respectively.

   

1-tetradecanoyl-2-eicosanoyl-sn-glycero-3-phosphocholine

1-tetradecanoyl-2-eicosanoyl-sn-glycero-3-phosphocholine

C42H84NO8P (761.5934)


   

1,2-diheptadecanoyl-sn-glycero-3-phosphocholine

1,2-diheptadecanoyl-sn-glycero-3-phosphocholine

C42H84NO8P (761.5934)


   

1-tridecanoyl-2-heneicosanoyl-sn-glycero-3-phosphocholine

1-tridecanoyl-2-heneicosanoyl-sn-glycero-3-phosphocholine

C42H84NO8P (761.5934)


   

1-heneicosanoyl-2-hexadecanoyl-glycero-3-phosphoethanolamine

1-heneicosanoyl-2-hexadecanoyl-glycero-3-phosphoethanolamine

C42H84NO8P (761.5934)


   

phosphatidylcholine 34:0

phosphatidylcholine 34:0

C42H84NO8P (761.5934)


A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at C-1 and C-2 contain 34 carbons in total with 0 double bonds.

   

1-icosanoyl-2-tetradecanoyl-sn-glycero-3-phosphocholine

1-icosanoyl-2-tetradecanoyl-sn-glycero-3-phosphocholine

C42H84NO8P (761.5934)


A phosphatidylcholine 34:0 in which the 1- and 2-acyl groups are specified as icosanoyl (arachidyl) and tetradecanoyl (myristoyl) respectively.

   

MePC(33:0)

MePC(16:0_17:0)

C42H84NO8P (761.5934)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

dMePE(35:0)

dMePE(16:0_19:0)

C42H84NO8P (761.5934)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

Hex1Cer(36:0)

Hex1Cer(t18:0_18:0(1+O))

C42H83NO10 (761.6017)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

PC O-16:0/18:1;O

PC O-16:0/18:1;O

C42H84NO8P (761.5934)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

(2r)-n-[(2s,3s,4r,16r)-3,4-dihydroxy-16-methyl-1-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}nonadecan-2-yl]-2-hydroxyhexadecanimidic acid

(2r)-n-[(2s,3s,4r,16r)-3,4-dihydroxy-16-methyl-1-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}nonadecan-2-yl]-2-hydroxyhexadecanimidic acid

C42H83NO10 (761.6017)


   

n-(3,4-dihydroxy-16-methyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}nonadecan-2-yl)-2-hydroxyhexadecanimidic acid

n-(3,4-dihydroxy-16-methyl-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}nonadecan-2-yl)-2-hydroxyhexadecanimidic acid

C42H83NO10 (761.6017)


   

(2r)-n-[(2r,3s,4r)-3,4-dihydroxy-1-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}hexadecan-2-yl]-2-hydroxyicosanimidic acid

(2r)-n-[(2r,3s,4r)-3,4-dihydroxy-1-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}hexadecan-2-yl]-2-hydroxyicosanimidic acid

C42H83NO10 (761.6017)


   

n-(3,4-dihydroxy-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}hexadecan-2-yl)-2-hydroxyicosanimidic acid

n-(3,4-dihydroxy-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}hexadecan-2-yl)-2-hydroxyicosanimidic acid

C42H83NO10 (761.6017)